Back to News
Market Impact: 0.2
India’s Cheap Weight-Loss Drugs Get A Reality Check
Source: Bloomberg
Healthcare & BiotechConsumer Demand & RetailTechnology & InnovationMarket Technicals & Flows
Despite GLP-1 weight-loss drugs reportedly costing as little as $14 per month in India, demand has been slower than expected. The article points to non-price barriers such as lingering stigma and hesitant prescribing by doctors, suggesting uptake is being constrained beyond affordability.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
More News
- Why is LG Innotek stock plunging today?
- RBI Tightens Rupee Defense as Pricey Crude, Foreign Outflows Bite: USD/INR
- Why is SK Hynix stock sliding today?
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom
- CXMT: How big is its market threat to Samsung, SK Hynix and Micron?
- Iran War’s End Will Be Turning Point for India, Amundi Arm Says